How High Cholesterol And Hypertension Increase Heart Disease Risks In Younger Adults

Health & Lifestyle
582

Listen to article (english)

Translate to Spanish or other 102 languages!

Experts say it’s important for younger adults to monitor their blood pressure. Image for illustration purposes
Experts say it’s important for younger adults to monitor their blood pressure. Image for illustration purposes

Medical News Today

- Advertisement -
  • In a new study, researchers say younger people may be more vulnerable to developing cardiovascular problems than previously believed.
  • They say young adults need to pay more attention to cardiovascular risk indicators such as cholesterol and high blood pressure at an early age.
  • Experts say early lifestyle modifications can reduce the risk of heart problems later in life.

Cardiovascular issues aren’t just a concern for the young at heart.

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/how-high-cholesterol-and-hypertension-increase-heart-disease-risks-in-younger-adults

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
DHR Health Brownsville Leads the Way in Minimally Invasive Robotic Surgery
Next article
Good News and Bad News About Angina

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -